Blanket Purchase Agreement V797D50358-VA24816A0004

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded multiple blanket purchase agreement calls against the Pharmaceuticals and Drugs Federal Supply Schedule to CSL Behring L.L.C. totaling over $20 million. The BPAs provide for the delivery of pharmaceutical products including the intravenous immunoglobulin Privigen to various VA medical facilities located in Pennsylvania, Florida, and Georgia. Performance will take place in King of...

Adma Biologics, Inc. has been awarded a single-award Blanket Purchase Agreement (BPA) by the National Acquisition Center with a ceiling value of $49 million for the supply of ASCENIV and BIVIGAM, plasma-derived therapeutic pharmaceuticals. The BPA was awarded on August 1, 2024, and extends through July 31, 2026, with no small business set-aside applied. As the prime contractor, Adma Biologics will supply these specialized hematology-related products to federal agencies, primarily supporting...

Immunogen Inc., a subsidiary of AbbVie Inc., was awarded a multiple-award Federal Supply Schedule contract on June 15, 2023, under General Services Administration schedule 61-IB (Pharmaceuticals and Drugs). This civilian contract, funded by the Department of Veterans Affairs' Veterans Integrated Service Network 12, carries a ceiling value of $225,000 and extends through June 14, 2028. The contract encompasses drugs, pharmaceuticals, and hematology-related products, with pricing subject to Public...

The Federal Supply Schedule (FSS) contract #36F79724D017E, awarded to Adma Biologics, Inc., provides the Department of Veterans Affairs (VA) and its Veterans Integrated Service Network 12 (VISN 12) with access to a variety of pharmaceutical and hematology-related products. The contract has a ceiling value of $25,000 and runs through July 14, 2024. Adma Biologics, a for-profit organization, specializes in plasma-derived therapeutics, with specific products referenced including ASCENIV and...

This Blanket Purchase Agreement, awarded December 6, 2022, by the Department of Veterans Affairs National Acquisition Center to Kedrion Biopharma Inc., establishes a single-award, non-set-aside vehicle for the supply of Ryplazim, a specialty pharmaceutical therapy indicated for plasminogen deficiency type 1. The contract is structured under the General Services Administration Pharmaceuticals and Drugs schedule (FSS-61-IB) and carries a ceiling value of $6,358,550 with a performance period...

Grifols USA LLC was awarded a $1.381 billion multiple-award Federal Supply Schedule contract on May 1, 2022, for the provision of drugs, pharmaceuticals, and hematology-related products under General Services Administration Schedule 61-IB (Pharmaceuticals and Drugs). The contract, which extends through April 30, 2027, is funded by Veterans Integrated Service Network 12 and carries no set-aside designation, indicating open competition among large businesses. Under this primary indefinite delivery...

This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Immucor Inc., a manufacturer of blood banking reagents and diagnostic products. The BPA facilitates recurring purchases of Immucor's bulk blood bank reagents on an as-needed basis, as evidenced by the multiple firm-fixed price call orders issued between January 2018 and March 2020 totaling approximately $149,000. Performance takes place at Immucor's location in Norcross, Georgia. The original...

This Blanket Purchase Agreement, awarded by the Department of Veterans Affairs National Acquisition Center on April 5, 2022, establishes a single-award contract vehicle for the procurement of ALBUMINEX albumin products. The prime contractor, Bio Products Laboratory LIMITED (UEI: ZMT1KZGKDCX3), is an international pharmaceutical manufacturer specializing in albumin and related blood products. The contract carries a ceiling value of $1,125,000 and operates under the Pharmaceuticals and Drugs...

Adma Biologics, Inc. was awarded a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs master schedule (FSS-61-IB) by the Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs. This multiple-award FSS contract, awarded on July 15, 2024, carries a ceiling value of $1,549,720 and extends through July 14, 2029. The contract involves no set-aside provisions and authorizes the procurement of drugs, pharmaceuticals, and...

CSL Behring L.L.C. was awarded a Blanket Purchase Agreement by the National Acquisition Center, a civilian federal agency, for the procurement of HAEGARDA, a C1 inhibitor medication used to treat hereditary angioedema. The contract carries a ceiling value of $17.5 million and spans from the award date of September 30, 2021, through September 29, 2026. This single-award, non-set-aside BPA is established under CSL Behring's broader Federal Supply Schedule contract for Pharmaceuticals and Drugs...